Last reviewed · How we verify
NCT03112395
Local Application of Combined Optical and Magnetic Stimulation (COMS) for Treatment of Chronic Wounds: Safety Evaluation
NA trial testing Pio Medical Device in Leg Ulcers Venous in 36 participants. Completed in 4 June 2020.
4 June 2020
Quick facts
| Lead sponsor | Piomic Medical AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 25 April 2017 |
| Primary completion | 4 June 2020 |
| Estimated completion | 4 June 2020 |
| Sites | 3 locations across Switzerland |
Drugs / interventions tested
- Pio Medical Device
Conditions studied
- Leg Ulcers Venous — all drugs for Leg Ulcers Venous →
- Leg Ulcer Arterial — all drugs for Leg Ulcer Arterial →
- Leg Ulcer Mixed — all drugs for Leg Ulcer Mixed →
Sponsor
Piomic Medical AG
Who can join
Adults 18 to 90, any sex, with Leg Ulcers Venous or Leg Ulcer Arterial. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The demographic shift and the increasing prevalence of chronic wounds represent major challenges for modern health care systems. Classic chronic wounds (venous ulcer, arterial ulcer, mixed ulcer) persist for months or years with a very slow or even no healing progress. Patients suffer from pain and immobility, which dramatically reduces their quality of life. Complications such as infections or tissue necrosis can lead to a bad outcome and amputation of extremities. The Pio device offers a non-invasive and non-toxic therapeutic approach. The system combines the technologies of pulse modulated magnetic fields and light emission locally applied to the wound area. The investigational medical device represents a promising combinational therapeutic approach to synergistically increase the tissues regenerative potential. By stimulating electrophysiological processes at the site of injury, the cells regain its capacity to efficiently regenerate the injured or diseased tissue. It is expected that the patient benefits from a faster healing process, reduced inflammation as well as an improved overall treatment outcome.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Concurrent Optical- and Magnetic-Stimulation-Induced Changes on Wound Healing Parameters, Analyzed by Hyperspectral Imaging: An Exploratory Case Series.
Traber J, Wild T, Marotz J, Berli MC, et al · · 2023 · cited 4× · PMID 37508777 · DOI 10.3390/bioengineering10070750
Verify or expand the search:
- PubMed search for NCT03112395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Leg Ulcers Venous
Currently open trials in the same condition.
- NCT06153589 — Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03112395 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Piomic Medical AG
- Last refreshed: 30 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03112395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing